Global Liquid Biopsy Market Size & Outlook, 2023-2030

The liquid biopsy industry worldwide is expected to reach a projected revenue of US$ 23,476.3 million by 2030. A compound annual growth rate of 11.9% is expected of the worldwide liquid biopsy industry from 2024 to 2030.
Revenue, 2023 (US$M)
$10,690.5
Forecast, 2030 (US$M)
$23,476.3
CAGR, 2024 - 2030
11.9%
Report Coverage
Worldwide

Global liquid biopsy market highlights

  • The global liquid biopsy market generated a revenue of USD 10,690.5 million in 2023 and is expected to reach USD 23,476.3 million by 2030.
  • The market is expected to grow at a CAGR (2024 - 2030) of 11.9% by 2030.
  • In terms of segment, blood sample accounted for a revenue of USD 7,827.5 million in 2023.
  • Blood Sample is the most lucrative type segment registering the fastest growth during the forecast period.
  • In terms of region, North America was the largest revenue generating market in 2023.
  • Country-wise, Saudi Arabia is expected to register the highest CAGR from 2024 to 2030.

Global data book summary

Market revenue in 2023USD 10,690.5 million
Market revenue in 2030USD 23,476.3 million
Growth rate11.9% (CAGR from 2023 to 2030)
Largest segmentBlood sample
Fastest growing segmentBlood Sample
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationBlood Sample

Other key industry trends

  • In terms of revenue, the North America accounted for 50.8% of the global liquid biopsy market in 2023.
  • By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
  • By country, Saudi Arabia is the fastest growing regional market and is projected to reach USD 70.3 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Liquid Biopsy Market Companies

Name Profile # Employees HQ Website

Global liquid biopsy market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to liquid biopsy market will help companies and investors design strategic landscapes.


Blood sample was the largest segment with a revenue share of 73.22% in 2023. Horizon Databook has segmented the Global liquid biopsy market based on blood sample covering the revenue growth of each sub-segment from 2018 to 2030.


  • Global Liquid Biopsy Type Outlook (Revenue, USD Million, 2018-2030)
    • Blood Sample
    • Others
  • Global Liquid Biopsy Biomarker Outlook (Revenue, USD Million, 2018-2030)
    • Circulating Tumor Cells (CTCs)
    • Circulating Nucleic Acids
    • Exosomes/ Microvesicles
    • Circulating Proteins
  • Global Liquid Biopsy Technology Outlook (Revenue, USD Million, 2018-2030)
    • Multi-gene-parallel Analysis (NGS)
    • Single Gene Analysis (PCR Microarrays)
  • Global Liquid Biopsy Application Outlook (Revenue, USD Million, 2018-2030)
    • Cancer
      • Lung Cancer
      • Prostate Cancer
      • Breast Cancer
      • Colorectal Cancer
      • Leukemia
      • Gastrointestinal Cancer
      • Others
    • Reproductive Health
    • Others
  • Global Liquid Biopsy End Use Outlook (Revenue, USD Million, 2018-2030)
    • Hospitals and Laboratories
    • Specialty Clinics
    • Academic and Research Centers
    • Others
  • Global Liquid Biopsy Clinical Application Outlook (Revenue, USD Million, 2018-2030)
    • Therapy Selection
    • Treatment Monitoring
    • Early Cancer Screening
    • Recurrence Monitoring
    • Others
  • Global Liquid Biopsy Product Outlook (Revenue, USD Million, 2018-2030)
    • Instruments
    • Consumables Kits and Reagents
    • Software and Services

Reasons to subscribe to Global liquid biopsy market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Global liquid biopsy market databook

  • Our clientele includes a mix of liquid biopsy market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of global-level data and insights on the Global liquid biopsy market , including forecasts for subscribers. This global databook contains high-level insights into Global liquid biopsy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Global liquid biopsy market size, by regions, 2018-2030 (US$M)

Top 10 countries: Liquid biopsy market size, 2023 (US$M)

Global liquid biopsy market share, by type, 2023 & 2030 (%, US$M)

Liquid biopsy market: Opportunity assessment by country

Global liquid biopsy market, by region, 2023 (US$M)

Global liquid biopsy market size, by regions, 2018-2030 (US$M)

Type 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 CAGR
North America 2,696.1 2,868.6 3,167.7 3,797.8 4,552.4 5,427.0 6,149.6 6,857.6 7,630.2 8,482.7 9,421.5 10,469.0 11,638.3 11.5%
Europe 1,611.3 1,719.5 1,904.5 2,290.1 2,753.4 3,292.4 3,742.0 4,185.6 4,671.4 5,209.2 5,803.6 6,468.8 7,213.6 11.9%
Asia Pacific 693.0 751.0 844.4 1,030.6 1,257.3 1,525.3 1,758.5 1,994.8 2,257.4 2,552.0 2,881.9 3,255.3 3,678.2 13.4%
Latin America 130.4 139.7 155.4 187.7 226.7 272.2 310.7 349.0 391.1 438.0 490.0 548.4 614.1 12.3%
MEA 92.7 97.3 105.9 125.2 147.9 173.7 193.8 212.8 233.0 254.8 278.3 304.0 332.1 9.7%
Overall 5,223.5 5,576.1 6,178.0 7,431.4 8,937.7 10,690.5 12,154.6 13,599.8 15,183.0 16,936.7 18,875.3 21,045.5 23,476.3 11.9%

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more